[Congressional Record Volume 146, Number 28 (Tuesday, March 14, 2000)]
[House]
[Page H937]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
TUBERCULOSIS, A WORLDWIDE EPIDEMIC
The SPEAKER pro tempore. Under the Speaker's announced policy of
January 19, 1999, the gentleman from Ohio (Mr. Brown) is recognized
during morning hour debates for 5 minutes.
Mr. BROWN of Ohio. Madam Speaker, remember when we were children, in
some cases 30, 40, 50 years ago, tuberculosis clinics were closing in
virtually every community in America. I remember growing up in
Mansfield, Ohio, in the 1950s and 1960s; and I remember that
tuberculosis clinic was closed there because Americans realized that
tuberculosis was not really much of a problem in the United States of
the 1960s or 1970s or 1980s.
People are surprised in this country, Members of Congress are
surprised, citizens are surprised, to learn that tuberculosis in 1999
killed 2 million people around the world. It killed more people in 1999
around the world than in any year in history. Tuberculosis is one of
the greatest infectious disease killers of adults worldwide, killing
someone every 15 seconds. It is the biggest killer of young women
around the world. It is the biggest killer of people with HIV/AIDS. Of
the deaths from AIDS in Africa, literally one-third of those deaths
actually are from tuberculosis.
The World Health Organization estimates that one-third of the world's
population of the 6 billion people in the world, some 2 billion are
infected with the bacteria that causes tuberculosis, including an
estimated 10 to 15 million people in the United States.
In India, 1,300 people a day in India, 1,300 people a day die from
tuberculosis. An estimated 8 million people around the world develop
active TB each year. It is spreading as a result of inadequate
treatment, and it is a disease that knows no national borders; and it
is becoming more and more of a problem in the United States. The threat
that TB poses for Americans derives, one, from the global spread of
tuberculosis and, second, from the emergence and spread of strains of
tuberculosis that are multidrug resistant.
In the U.S., TB treatment is normally only about $2,000 per patient
in the United States and in developing countries as little as $15 or
$20 or no more than $100 per patient, regular, sort of standard
tuberculosis. The costs can go up to as much as $250,000 a patient to
treat multidrug resistant tuberculosis, and the treatment is much less
likely to be successful.
Multidrug-resistant TB kills more than half those infected even in
the United States and other industrialized nations.
Madam Speaker, the gentlewoman from Maryland (Mrs. Morella),
Republican from Maryland, and I are bipartisanly sponsoring legislation
which will authorize an appropriation of $100 million to U.S. Agency
for International Development, USAID, for the purpose of diagnosing and
treating TB in high-incidents countries. The director general of the
World Health Organization, Secretary General Gro Brundtland, said that
tuberculosis is not a medical problem, it is a political problem. We
know how to take care of people with tuberculosis. We know how to treat
tuberculosis. The question is the political will to do it, the
resources available to do it.
Tuberculosis experts estimate that it will cost an additional $1
billion each year worldwide to control this disease.
{time} 1300
The great majority of funds are used for the direct implementation of
DOTS Tuberculosis Control Program, DOTS stands for directly observed
treatment, where a person infected with TB must take medication every
day for up to 6 months, and, if they stop taking it, then even when
they stop coughing up blood or stop showing symptoms of TB, their
multi-drug-resistant TB can come back. That is why it is simple to
treat, but difficult to make sure that people take their medicine every
day.
The medicine is there. The will needs to be there, the outreach
workers need to be available, whether it is in the United States or
India or Nigeria or wherever across the world.
Resources under our legislation will be used primarily in those
countries having the highest incidence of tuberculosis. It is a problem
worldwide that we as a wealthy country have a moral obligation to deal
with. It is a problem worldwide that we have a practical reason to deal
with, because tuberculosis, with more tourism, travel, with more
business development, with more trade, with more airplanes,
tuberculosis has come into our country in greater and greater
incidence, unless we in fact try to deal with tuberculosis
internationally.
That is why we already have bipartisan support for the legislation
that the gentlewoman from Maryland (Mrs. Morella) and I are working on.
That is why I ask other Members to join us in cosponsoring this
legislation which I will be introducing next week. March 24 is
International Tuberculosis Day. We will be introducing the bill next
week, the week of March 24, and ask other Members to cosponsor it.
____________________